Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma.

Park CK, Kim JH, Nam DH, Kim CY, Chung SB, Kim YH, Seol HJ, Kim TM, Choi SH, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW.

Neuro Oncol. 2013 Aug;15(8):1096-101. doi: 10.1093/neuonc/not069. Epub 2013 Jun 25.

2.

Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM.

J Clin Oncol. 2010 Aug 20;28(24):3838-43. doi: 10.1200/JCO.2010.30.0582. Epub 2010 Jul 19.

3.

Survival and functional status after resection of recurrent glioblastoma multiforme.

Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB.

Neurosurgery. 1998 Apr;42(4):709-20; discussion 720-3.

PMID:
9574634
4.

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST.

J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6.

PMID:
21548745
5.

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Oppenlander ME, Wolf AB, Snyder LA, Bina R, Wilson JR, Coons SW, Ashby LS, Brachman D, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N.

J Neurosurg. 2014 Apr;120(4):846-53. doi: 10.3171/2013.12.JNS13184. Epub 2014 Jan 31.

PMID:
24484232
6.

Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.

Yong RL, Wu T, Mihatov N, Shen MJ, Brown MA, Zaghloul KA, Park GE, Park JK.

J Neurosurg. 2014 Oct;121(4):802-9. doi: 10.3171/2014.6.JNS132038. Epub 2014 Jul 25.

PMID:
25061868
7.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
8.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
9.

Repeat-surgery at Glioblastoma recurrence, when and why to operate?

Ening G, Huynh MT, Schmieder K, Brenke C.

Clin Neurol Neurosurg. 2015 Sep;136:89-94. doi: 10.1016/j.clineuro.2015.05.024. Epub 2015 May 28.

PMID:
26092644
10.

The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.

De Bonis P, Fiorentino A, Anile C, Balducci M, Pompucci A, Chiesa S, Sica G, Lama G, Maira G, Mangiola A.

Clin Neurol Neurosurg. 2013 Jul;115(7):883-6. doi: 10.1016/j.clineuro.2012.08.030. Epub 2012 Sep 7.

PMID:
22959214
11.

Primary glioblastoma multiforme in younger patients: a single-institution experience.

Ulutin C, Fayda M, Aksu G, Cetinayak O, Kuzhan O, Ors F, Beyzadeoglu M.

Tumori. 2006 Sep-Oct;92(5):407-11.

PMID:
17168433
12.

Benefit of tumor resection for recurrent glioblastoma.

Quick J, Gessler F, Dützmann S, Hattingen E, Harter PN, Weise LM, Franz K, Seifert V, Senft C.

J Neurooncol. 2014 Apr;117(2):365-72. doi: 10.1007/s11060-014-1397-2. Epub 2014 Feb 15.

PMID:
24535317
13.

Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.

Chen MW, Morsy AA, Liang S, Ng WH.

World Neurosurg. 2016 Mar;87:439-45. doi: 10.1016/j.wneu.2015.10.051. Epub 2015 Nov 14.

PMID:
26585720
14.

Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).

Mrugala MM, Engelhard HH, Dinh Tran D, Kew Y, Cavaliere R, Villano JL, Annenelie Bota D, Rudnick J, Love Sumrall A, Zhu JJ, Butowski N.

Semin Oncol. 2014 Oct;41 Suppl 6:S4-S13. doi: 10.1053/j.seminoncol.2014.09.010. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e33-43.

15.

Efficacy of clinical prognostic factors on survival in patients with glioblastoma.

Tugcu B, Postalci LS, Gunaldi O, Tanriverdi O, Akdemir H.

Turk Neurosurg. 2010 Apr;20(2):117-25. doi: 10.5137/1019-5149.JTN.2461-09.4.

16.

The association of subventricular zone involvement at recurrence with survival after repeat surgery in patients with recurrent glioblastoma.

Sonoda Y, Saito R, Kanamori M, Kumabe T, Uenohara H, Tominaga T.

Neurol Med Chir (Tokyo). 2014;54(4):302-9. Epub 2013 Dec 27.

17.

Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?

Nakamura H, Murakami R, Hirai T, Kitajima M, Yamashita Y.

Acta Radiol. 2013 Mar 1;54(2):214-20. doi: 10.1258/ar.2012.120525. Epub 2012 Nov 8.

PMID:
23138021
18.

The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.

Chambless LB, Kistka HM, Parker SL, Hassam-Malani L, McGirt MJ, Thompson RC.

J Neurooncol. 2015 Jan;121(2):359-64. doi: 10.1007/s11060-014-1640-x. Epub 2014 Oct 26.

PMID:
25344883
19.

The impact of enrollment in clinical trials on survival of patients with glioblastoma.

Shahar T, Nossek E, Steinberg DM, Rozovski U, Blumenthal DT, Bokstein F, Sitt R, Freedman S, Corn BW, Kanner AA, Ram Z.

J Clin Neurosci. 2012 Nov;19(11):1530-4. doi: 10.1016/j.jocn.2012.04.005. Epub 2012 Sep 16.

PMID:
22989795
20.

Supplemental Content

Support Center